Gabelli Funds LLC Charles River Laboratories International, Inc. Transaction History

Gabelli Funds LLC

$12.8 Billion
Q3 2024

A detailed history of Gabelli Funds LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Gabelli Funds LLC holds 20,200 shares of CRL stock, worth $3.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

20,200

Previous 20,200 -0.0%

Holding current value

$3.8 Million

Previous $4.17 Million 4.63%

% of portfolio

0.03%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$197.11 - $250.07 $150,789 - $191,303	-765 Reduced 3.65%	20,200 $4.4 Million
Q3 2022 Nov 10, 2022	SELL	$182.44 - $250.54 $681,413 - $935,766	-3,735 Reduced 15.12%	20,965 $4.13 Million
Q2 2022 Aug 12, 2022	BUY	$204.13 - $302.4 $2.49 Million - $3.69 Million	12,200 Added 97.6%	24,700 $5.29 Million
Q1 2022 May 13, 2022	BUY	$255.51 - $362.11 $1.79 Million - $2.53 Million	7,000 Added 127.27%	12,500 $3.55 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $5.12 Million - $6.3 Million	-13,750 Reduced 71.43%	5,500 $2.27 Million
Q2 2021 Aug 13, 2021	SELL	$294.17 - $371.65 $841,620 - $1.06 Million	-2,861 Reduced 12.94%	19,250 $7.12 Million
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $1.75 Million - $2.1 Million	-7,000 Reduced 24.05%	22,111 $6.41 Million
Q3 2020 Nov 06, 2020	SELL	$175.56 - $226.45 $307,230 - $396,287	-1,750 Reduced 5.67%	29,111 $6.59 Million
Q1 2020 May 14, 2020	SELL	$98.9 - $178.34 $494,500 - $891,700	-5,000 Reduced 13.94%	30,861 $3.9 Million
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $346,637 - $420,090	2,750 Added 8.31%	35,861 $5.48 Million
Q3 2019 Nov 01, 2019	BUY	$125.07 - $143.67 $514,162 - $590,627	4,111 Added 14.18%	33,111 $4.38 Million
Q2 2019 Aug 02, 2019	BUY	$123.4 - $148.55 $308,500 - $371,375	2,500 Added 9.43%	29,000 $4.12 Million
Q1 2019 May 02, 2019	SELL	$104.82 - $146.73 $52,410 - $73,365	-500 Reduced 1.85%	26,500 $3.85 Million
Q4 2018 Jan 30, 2019	SELL	$105.09 - $137.23 $525,450 - $686,150	-5,000 Reduced 15.63%	27,000 $3.06 Million
Q3 2018 Nov 02, 2018	SELL	$112.11 - $134.54 $1.12 Million - $1.35 Million	-10,000 Reduced 23.81%	32,000 $4.31 Million
Q2 2018 Aug 10, 2018	BUY	$102.37 - $117.25 $1.54 Million - $1.76 Million	15,000 Added 55.56%	42,000 $4.72 Million
Q1 2018 May 09, 2018	BUY	$98.19 - $115.2 $289,267 - $339,379	2,946 Added 12.25%	27,000 $2.88 Million
Q4 2017 Feb 02, 2018	BUY	$100.43 - $118.09 $1.06 Million - $1.25 Million	10,554 Added 78.18%	24,054 $2.63 Million
Q3 2017 Nov 01, 2017	BUY	$96.72 - $109.26 $1.31 Million - $1.48 Million	13,500	13,500 $1.46 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Charles River Laboratories International, Inc. Transaction History